Els Wauters Selected Research

Els Wauters Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 04/2013
13	COVID-19 01/2024 - 01/2021
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2014
7	Lung Neoplasms (Lung Cancer) 07/2023 - 01/2017
3	Infections 06/2023 - 08/2014
2	Pneumonia (Pneumonitis) 05/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 08/2014
2	Fibrosis (Cirrhosis) 01/2021 - 08/2014
2	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2018 - 01/2013
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2015 - 08/2014
1	Pulmonary Aspergillosis 01/2024
1	Aspergillosis 01/2024
1	Colitis 01/2023
1	Coinfection 11/2022
1	Human Influenza (Influenza) 11/2022
1	Critical Illness (Critically Ill) 11/2022
1	Viral Pneumonia 11/2022
1	Acute Coronary Syndrome 10/2022
1	Stroke (Strokes) 10/2022
1	Heart Failure 10/2022
1	Myocarditis (Carditis) 10/2022
1	Transient Ischemic Attack 10/2022
1	Heart Valve Diseases (Valvular Heart Disease) 10/2022
1	Adenocarcinoma of Lung 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 10/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Emphysema 01/2018
1	Primary Graft Dysfunction 07/2015
1	Neoplasm Metastasis (Metastasis) 06/2015
1	Bronchiolitis 08/2014

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2014
4	Small Cytoplasmic RNAIBA 01/2024 - 01/2020
4	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2021
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
3	AntigensIBA 01/2023 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 11/2022 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2014
2	pyrimidineIBA 05/2019 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 06/2015
2	Estrogen ReceptorsIBA 04/2013 - 10/2011
1	Histones (Histone)IBA 01/2024
1	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2023
1	LigandsIBA 01/2023
1	Complement C5a (Complement 5a)IBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2022
1	ElafinIBA 11/2022
1	Secretory Leukocyte Peptidase InhibitorIBA 11/2022
1	Chemotactic FactorsIBA 11/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2022
1	ChemokinesIBA 11/2022
1	CytokinesIBA 11/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2022
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	Peptides (Polypeptides)IBA 09/2022
1	Tissue Kallikreins (Tissue Kallikrein)IBA 09/2022
1	Kallikreins (Kallikrein)IBA 09/2022
1	KininsIBA 09/2022
1	Peroxidase (Myeloperoxidase)IBA 09/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	alectinibIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	PerforinIBA 01/2022
1	Oxygen (Dioxygen)IBA 10/2021
1	InflammasomesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	CollagenIBA 01/2020
1	pembrolizumabIBA 10/2019
1	capmatinibIBA 01/2019
1	C-Reactive ProteinIBA 07/2018
1	SmokeIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	B7-H1 AntigenIBA 01/2017
1	atezolizumabIBA 01/2017
1	Prostaglandins DIBA 07/2015
1	Interleukin-17 ReceptorsIBA 07/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2015

Therapy/Procedure

8	Immunotherapy 01/2024 - 01/2017
5	Therapeutics 11/2022 - 06/2015
4	Lung Transplantation 07/2023 - 01/2013
2	Immunomodulation 01/2024 - 01/2023
2	Artificial Respiration (Mechanical Ventilation) 11/2022 - 10/2021
1	Chemoradiotherapy 01/2023
1	Critical Care (Surgical Intensive Care) 05/2022
1	Aftercare (After-Treatment) 01/2022